科兴制药：科益医药拟减持不超3%公司股份

澎湃新闻2025-06-04

6月4日晚间，科兴生物制药股份有限公司公告，截至本公告披露日，深圳科益医药控股有限公司（以下简称“科益医药”）直接持有公司131,778,347股，占公司总股本的比例为66.01%。科益医药本次拟通过集中竞价或大宗交易方式减持所持有的公司股份为不超过5,989,200 股，即不超过公司目前股份总数的3.00%。本次减持计划自公告披露之日起15个交易日后的3个月内（根据中国证券监督管理委员会及...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2540065123?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-06-04 20:09","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2540065123","market":"us","top_or_hot":-1,"title":"科兴制药：科益医药拟减持不超3%公司股份","media":"澎湃新闻","content":"<div>\n<p>6月4日晚间，科兴生物制药股份有限公司公告，截至本公告披露日，深圳科益医药控股有限公司（以下简称“科益医药”）直接持有公司131,778,347股，占公司总股本的比例为66.01%。科益医药本次拟通过集中竞价或大宗交易方式减持所持有的公司股份为不超过5,989,200 股，即不超过公司目前股份总数的3.00%。本次减持计划自公告披露之日起15个交易日后的3个月内（根据中国证券监督管理委员会及...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604201853a6fa40a2&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>科兴制药：科益医药拟减持不超3%公司股份</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n科兴制药：科益医药拟减持不超3%公司股份\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-04 20:09 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604201853a6fa40a2&s=b><strong>澎湃新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>6月4日晚间，科兴生物制药股份有限公司公告，截至本公告披露日，深圳科益医药控股有限公司（以下简称“科益医药”）直接持有公司131,778,347股，占公司总股本的比例为66.01%。科益医药本次拟通过集中竞价或大宗交易方式减持所持有的公司股份为不超过5,989,200 股，即不超过公司目前股份总数的3.00%。本次减持计划自公告披露之日起15个交易日后的3个月内（根据中国证券监督管理委员会及...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604201853a6fa40a2&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SVA","symbol_name":"科兴生物","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604201853a6fa40a2&s=b","article_id":"2540065123","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604201853a6fa40a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2540065123","pubTimestamp":1749038940,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"6月4日晚间，科兴生物制药股份有限公司公告，截至本公告披露日，深圳科益医药控股有限公司（以下简称“科益医药”）直接持有公司131,778,347股，占公司总股本的比例为66.01%。科益医药本次拟通过集中竞价或大宗交易方式减持所持有的公司股份为不超过5,989,200 股，即不超过公司目前股份总数的3.00%。本次减持计划自公告披露之日起15个交易日后的3个月内（根据中国证券监督管理委员会及上海证券交易所规定禁止减持的期间除外）进行。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"SVA":"科兴生物","BK4139":"生物科技"},"translate_title":"Kexing Pharmaceutical: Keyi Pharmaceutical plans to reduce its holdings by no more than 3% of the company's shares","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SVA":0.9},"content_text":"6月4日晚间，科兴生物制药股份有限公司公告，截至本公告披露日，深圳科益医药控股有限公司（以下简称“科益医药”）直接持有公司131,778,347股，占公司总股本的比例为66.01%。科益医药本次拟通过集中竞价或大宗交易方式减持所持有的公司股份为不超过5,989,200 股，即不超过公司目前股份总数的3.00%。本次减持计划自公告披露之日起15个交易日后的3个月内（根据中国证券监督管理委员会及上海证券交易所规定禁止减持的期间除外）进行。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.4","shortVersion":"4.42.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2540065123","isCrawlerRequest":true}